BSE filing, NSE: MKPL. Summary written from the filing by ALFA Finder's alert engine.
M K Proteins Ltd: key numbers
- Share price
- ₹3.67
- Market cap
- ₹137.8 Cr
- Revenue (annual)
- ₹382.9 Cr
- Net profit (annual)
- ₹6.83 Cr
- P/E (TTM)
- 29.3×Sector 38.3×
- Promoter holding
- 74.82%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from M K Proteins Ltd
All →M K Proteins Other Announcement
Standard quarterly shareholding pattern filing for M. K. Proteins Ltd for the quarter ended September 30, 2026.
M K Proteins Management Change
M. K. Proteins Ltd's shareholders approved the appointment of Ms. Aritika Garg as an Independent Director for a five-year term at the 14th AGM.
M K Proteins Annual General Meeting
M. K. Proteins Limited conducted its 14th Annual General Meeting on September 30, 2026. Shareholders considered financial statements, director appointments, and related party transaction approvals.
M K Proteins Other Announcement
M K Proteins Limited is providing the Annual Report for FY 2025-26 to shareholders via web links and QR codes, per Regulation 36(1)(b) of SEBI LODR.
M K Proteins Annual General Meeting
M K Proteins Limited has scheduled its 14th Annual General Meeting for September 30, 2026, and approved the associated notice and directors' report.
M K Proteins Management Change
M K Proteins Limited has appointed Ms. Aritika Garg as a Non-Executive Independent Director effective August 22, 2026.
Other board meeting outcome announcements
All →Popular Vehicles and Services Board Meeting Outcome
Popular Vehicles passed a circular resolution approving a routine AOA amendment on the common seal. A postal ballot notice and scrutinizer were also appointed.
R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.